Fertyl

Quick links to important sections

Fertyl

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fertyl

What is Fertyl? (Clomifene Citrate Overview)

Property Description
Active ingredient Clomifene Citrate (or Clomiphene Citrate)
Form Oral Tablet (Solid dosage form)
Pharmacological class Selective Estrogen Receptor Modulator (SERM)
Common use Ovulation Stimulant in anovulatory infertility
Origin Synthetic, non-steroidal compound

Fertyl: Identity and Pharmacological Classification

Fertyl is a medication defined by its active component, Clomifene Citrate, a synthetic, non-steroidal compound supplied as an oral tablet by manufacturers such as Ar-Ex Laboratories. This substance belongs to the pharmacological class of Selective Estrogen Receptor Modulators (SERMs). The SERM classification is a key differentiator, confirming that the drug operates by selectively binding to estrogen receptors to influence the body’s hormonal feedback system, rather than acting as a simple hormone replacement. The compound is composed of two geometric isomers, a feature contributing to its mixed estrogenic and anti-estrogenic effects.

High-Level Mechanism and Therapeutic Role

The general function of Clomifene Citrate is achieved by influencing the hormone control centers in the brain, including the hypothalamus and pituitary gland. By creating the perception of low estrogen, the drug prompts the pituitary gland to increase its output of the crucial fertility hormones Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This targeted, indirect hormonal stimulation is the principle by which the drug operates. Clomifene Citrate is clinically recognized as a common first-line therapy for women experiencing anovulatory or oligo-ovulatory infertility.

General Benefits and Unique Context

The therapeutic benefit of this oral medication is its ability to correct certain types of ovulatory dysfunction by encouraging the growth and maturation of ovarian follicles. Its oral administration offers a convenience advantage when compared to injectable fertility treatments. As an effective Ovulation Stimulant, its primary purpose is to initiate the essential reproductive processes required for controlled ovulation in women who would otherwise not release an egg.

What side effects are possible with Fertyl?

Possible Side Effects and Safety Information

Fertyl (Clomifene Citrate) has an officially documented safety profile characterized by categorized adverse reactions and specific usage constraints as defined by regulatory agencies like the FDA and EMA.


Frequency-Classified Adverse Reactions

The adverse reactions are categorized based on their expected frequency:

  • Very Common (Affecting more than 1 in 10 users): Vasomotor flushing (hot flushes) and ovarian enlargement are frequently reported reactions.
  • Common (Affecting up to 1 in 10 users): Gastrointestinal discomfort (e.g., abdominal pain, nausea, vomiting), headache, breast discomfort, and blurred vision are listed as common effects.
  • Uncommon to Rare: Less frequent effects include vertigo, depression, nervous tension, skin reactions (dermatitis/rash), and conditions affecting the eyes.

Clinically Significant Safety Considerations

The regulatory profile highlights several serious safety considerations:

  • Ovarian Hyperstimulation Syndrome (OHSS): This is a serious complication documented in official sources, which can progress rapidly and, in severe forms, is associated with thromboembolic events.
  • Vascular Risk: The label documents rare associations with thromboembolic events, including deep venous thrombosis and pulmonary embolism.
  • Visual Disturbances: Although commonly reported visual changes are often reversible, rare cases of significant and sometimes irreversible visual loss, including optic neuritis, have been documented in post-marketing reports.

Safety Restrictions and Context

Clomifene Citrate is contraindicated in individuals with active Liver Disease or a history of liver dysfunction, unexplained abnormal uterine bleeding, or certain types of ovarian cysts. The risk of ovarian tumors may be reinforced by prolonged use of one year or more. Furthermore, the official label documents an increased risk of both Multiple Pregnancies and Ectopic Pregnancy associated with therapy.

Overdose and Emergency Response

An overdose of Fertyl (Clomifene Citrate) is associated with several documented clinical manifestations. Regulator-listed symptoms may include gastrointestinal distress such as nausea and vomiting, in addition to vasomotor flushes (hot flashes). A primary concern is ovarian enlargement, which can cause pelvic or abdominal pain and distension.

Overdose exposure, especially at increased dosage or duration, has also been linked to visual disturbances, including blurring or the appearance of scotomata (blind spots) and flashes. These visual changes mandate the immediate discontinuation of the medication and require an ophthalmologic evaluation due to the documented risk of prolonged or irreversible vision loss.

In the event of a suspected overdose, regulatory guidance mandates that you seek immediate medical attention or contact a Poison Control center. Immediately call emergency services if the affected individual has collapsed, experienced a seizure, or has difficulty breathing.

Treatment for overdose is symptomatic and supportive, as there is no known specific antidote for Clomifene Citrate listed in official labeling. Management may involve appropriate supportive procedures such as gastric lavage, tailored to the patient’s clinical presentation.

Therapeutic Uses of Fertyl

Quick Facts: Uses of Fertyl

  • Condition Managed: Female infertility
  • Primary Action: Supports the induction of ovulation
  • Beneficial for: Women experiencing challenges with egg production (ovulatory dysfunction)
  • Associated Conditions: Used in the management of Polycystic Ovary Syndrome (PCOS)-related infertility

What Fertyl Treats: Main Uses and Benefits

Fertyl is a prescription medication utilized in the management of female infertility where the primary difficulty is related to ovulatory dysfunction. The drug supports the reproductive system by assisting in the process of ovulation—the release of a mature egg from the ovary. This action may increase the likelihood of conception in women who are experiencing an irregular or absent release of an egg.

The medication is frequently employed to support patients who have been diagnosed with Polycystic Ovary Syndrome (PCOS), a common cause of irregular or absent ovulation. Additionally, it may be a treatment option for certain cases of secondary amenorrhea, a condition characterized by the cessation of menstrual periods. It is considered a cornerstone in the initial therapeutic approach for appropriate patients with anovulatory infertility.

Treatment with this medication is initiated only after a thorough medical evaluation has been completed to confirm the underlying cause of the infertility. The overall goal of therapy is to help achieve successful ovulation, which is a necessary step toward pregnancy.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Fertyl?

Fertyl (Clomifene Citrate) is restricted to adult women who are experiencing ovulatory dysfunction and are not pregnant. Use of this medicine is not established in the pediatric population.

Groups Who Must Not Use Fertyl (Contraindications)

Official regulatory documents explicitly state that Fertyl is contraindicated if the patient is pregnant or has a known allergy to Clomifene Citrate.

Use is also prohibited in patients with pre-existing conditions, including active liver disease or a history of hepatic dysfunction, uncontrolled thyroid or adrenal disorders, or the presence of an organic intracranial lesion such as a pituitary tumor.

Additional absolute restrictions include undiagnosed abnormal uterine bleeding and ovarian cysts or enlargement that are not related to Polycystic Ovary Syndrome (PCOS).

Conditional Use

Lactation: The medicine is generally not recommended for women who are breastfeeding or lactating due to its potential to reduce milk production.

Comorbidities: Patients with uterine fibroids should use this medicine with caution due to the potential for the fibroids to enlarge during therapy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Fertyl (Clomifene Citrate) is focused on specific restrictions and monitoring requirements, with limited documentation of pharmacokinetic interactions.


Formal Prohibited Combinations

The co-administration of Clomifene Citrate with the medication Ospemifene is classified as a formal contraindicated combination. This strict restriction is based on a pharmacodynamic interaction risk due to both substances belonging to the Selective Estrogen Receptor Modulator (SERM) class, which can result in compounded effects on the body's hormonal systems.


Metabolic and Exposure Patterns

Official government prescribing information does not explicitly document any specific drug-drug interaction partners that significantly alter the systemic exposure of Clomifene Citrate through cytochrome P450 (CYP) enzymes or transport proteins. Consequently, the regulatory text does not impose mandatory timing rules for co-administration with other medicinal products.


Substance and Population-Specific Notes

Certain herbal or dietary supplements that have documented hormonal or estrogen-like properties, such as Black Cohosh or Chasteberry, are noted by some regulatory authorities as substances that may interact with the medication. A required population-specific interaction constraint exists for patients with a preexisting or family history of hyperlipidemia. For this patient group, the regulatory label mandates periodic monitoring of plasma triglycerides due to the drug’s potential to affect plasma lipid levels.

Mechanism of Action

Direct Targeting of Key Molecular Systems

Fertyl is characterized by its primary mechanistic focus on defined biological targets. It acts as an agonist or antagonist to directly influence the activity of specific receptor or enzyme systems. This interaction initiates a precise molecular event, altering the target component's functional state.

Modulation of Specific Signaling Pathways

Following primary target engagement, Fertyl alters signaling dynamics within defined neural or humoral pathways. It acts within well-characterized molecular cascades by influencing the release or metabolism of specific mediators. This regulatory step allows the molecular interaction to propagate into a systemic change across the affected pathway.

Driving Functional System Adjustment

The mechanism of Fertyl is used to influence core regulatory mechanisms underlying its effect profile. By modulating the cascade, it adjusts activity within the affected feedback loops. This process contributes to stabilizing the system and shaping the resulting physiological adjustments.

Dosage and Administration Information

How to Use Fertyl (Clomifene Citrate)

Fertyl is intended for oral administration as a tablet and is used within a structured cyclic regimen that is not continuous daily therapy. The administration protocol mandates that treatment be managed by physicians experienced in gynecologic or endocrine disorders, and a pelvic examination is a required procedural step before starting the first and each subsequent course.

The standard initial dosing regimen is 50 mg taken once daily for five consecutive days. Administration is precisely timed, with the course typically beginning on or about the fifth day of the menstrual cycle. If ovulation does not occur, the dose may be increased for a subsequent course up to a 100 mg maximum per day. The 100 mg dose is achieved by taking two 50 mg tablets as a single daily administration.

Subsequent courses should only be initiated no sooner than 30 days following the previous course. For patients with Polycystic Ovary Syndrome (PCOS), standard clinical practices emphasize using the lowest recommended dose and shortest duration for the initial course. The total number of treatment cycles is recommended to not exceed about six courses in total to define the scope of the overall treatment protocol. This structured approach defines the standardized method for administering the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fertyl (Clomifene Citrate)


Evidence for Use in Anovulatory Infertility and PCOS

The primary research for Fertyl has focused on the study of anovulatory infertility in women experiencing difficulty with egg release, including many women diagnosed with Polycystic Ovary Syndrome (PCOS). The research structure includes many Randomized Controlled Trials (RCTs), a type of study frequently used for clinical evaluation, alongside Systematic Reviews. Researchers examined outcomes like the Ovulation Rate, the number of pregnancies, and the Live Birth Rate. These studies primarily included adult women confirmed to have difficulty with ovulation.

Findings describe patterns where the measured Ovulation Rate was generally higher than the concurrent measurements of Pregnancy Rate or Live Birth Rate. This difference is an element that researchers consider when evaluating reproductive outcomes. The available research largely describes short-term changes, with most treatment cycles observed over three to six months to assess the immediate reproductive response.


Research on Clomifene Citrate Resistance

Research has also explored a specific situation that was defined in studies as Clomifene Citrate Resistance—women who did not ovulate after taking the highest tested dose of the medication. Studies for this group often took the form of Randomized Controlled Trials (RCTs) investigating if combining Fertyl with other specific medications, such as metformin, was associated with an Ovulation Rate. Findings indicate that some of these combination approaches may result in ovulation, but these studies generally involved smaller sample sizes compared to the trials for the primary, first-time use.


Key Limitations and Areas of Uncertainty

Long-term effects are not fully established regarding the medication's overall impact on reproductive health or durability of the response over a number of years. The limited follow-up durations contribute to a lack of comprehensive long-term information regarding the stability of the fertility status after treatment ends. Furthermore, the available data for certain subgroups, such as those with certain comorbid conditions, remain insufficient to draw broad conclusions. Research in these areas is ongoing to provide more complete context.

Key Studies & References

  1. Clomiphene Citrate Clinical Review (StatPearls)
  2. Clomiphene Citrate: Uses, dosage, side effects - MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Fertyl (FAQ)


Q: How quickly should I expect to see an effect from Fertyl?

A: Ovulation is generally observed to occur 5 to 10 days following the completion of the five-day treatment course. This timing is based on the medicine’s expected action on the body's hormonal systems, as described in the official prescribing information.


Q: What happens if I miss a day of taking Fertyl?

A: Regulatory guidance describes that if a dose is missed, the recommended action is taking it as soon as it is remembered. When it is almost time for the next scheduled dose, the official label directs the individual to consult a health care provider for specific guidance and states that a double dose should be avoided.


Q: Is Fertyl prescription-only, or can it be bought over the counter?

A: Fertyl (Clomifene Citrate) is categorized by major regulatory bodies as a prescription-only medicine. It is not available for purchase over the counter and is intended for use under the management of a physician.


Q: Is it necessary to avoid alcohol completely while using Fertyl?

A: The official regulatory profile does not explicitly impose a mandatory restriction on alcohol consumption. Official prescribing information notes that the medicine is prohibited for use in patients with active liver disease. This is a point of consideration since both the drug and alcohol are processed by the liver.


Q: Can I drive or operate machinery while taking Fertyl?

A: Official warnings document that visual symptoms, which can be a common side effect of this medicine, may make activities such as driving or operating machinery more hazardous than usual. Caution is particularly advised under conditions of variable or low lighting.


Q: Is there a generic version of Fertyl available?

A: Yes, regulatory documents indicate that the active ingredient, Clomifene Citrate, is available in generic formulations. These generic versions are chemically equivalent to the brand name product.


Q: What is the difference between Fertyl and a vitamin supplement?

A: Fertyl is officially classified as a non-steroidal medication belonging to the Selective Estrogen Receptor Modulator (SERM) class. Its function is to actively influence hormone production to encourage ovulation. This pharmacological action is fundamentally different from that of a vitamin or dietary supplement.


Q: Why do some people say they felt worse when they first started Fertyl?

A: The perception of 'feeling worse' may be explained by the commonly reported adverse reactions documented in the regulatory profile. These often include vasomotor flushing, abdominal discomfort, nausea, vomiting, and headaches, which are known temporary effects when first initiating the medication.


Q: What if I'm taking herbal supplements—do they interact with Fertyl?

A: Regulatory authorities note that certain herbal or dietary supplements may potentially interact with this medicine. The regulatory caution specifically concerns those supplements that are documented to have hormonal or estrogen-like properties.


Q: Does Fertyl affect fertility or getting pregnant?

A: Studies and official information indicate that the medicine is used to influence the Ovulation Rate and has been studied based on outcomes like Pregnancy Rate and Live Birth Rate. However, regulatory documents also state that use is associated with an increased risk of both multiple pregnancies and ectopic pregnancy.


Q: How long does the effect of Fertyl last after stopping treatment?

A: Official research documentation states that long-term effects regarding the durability of the response and fertility status after treatment ends are not fully established. This is due to limited follow-up durations in the current studies for this medicine.


Q: What are the most common reasons someone might stop taking Fertyl?

A: The official information describes several specific conditions that prohibit continued use, such as developing Ovarian Hyperstimulation Syndrome (OHSS), becoming pregnant, or reaching the officially recommended maximum number of treatment courses.


Q: Can adolescents or children use Fertyl?

A: Use of this medicine is officially restricted to adult women experiencing ovulatory dysfunction. The safety and effectiveness of Fertyl has not been established for use in the pediatric population, according to regulatory documents.


Q: Will I have withdrawal symptoms if I stop using Fertyl suddenly?

A: Fertyl is not classified as a controlled substance by regulatory bodies, and official information does not document withdrawal symptoms or dependence concerns associated with this medicine.


Q: What is the primary ingredient in Fertyl?

A: The sole active ingredient in Fertyl is Clomifene Citrate. This is a non-steroidal chemical compound.


Q: Is the 'Mechanism of Action' of Fertyl fully understood by scientists?

A: Scientific reviews indicate that while the drug’s general role in influencing the body's hormonal control centers is well known, the precise mechanism by which it stimulates ovulation is not yet fully understood by scientists. This area remains a subject of ongoing research.


Q: Is it true that Fertyl can change the results of some laboratory tests?

A: Yes, official information confirms that the medicine has the potential to affect certain laboratory test results. This includes, but is not limited to, those related to hormonal levels and plasma lipids.


Q: What are the storage guidelines for Fertyl?

A: The medication should be kept at Controlled Room Temperature, which is typically between 15 C and 30 C. It must be stored in a dry, tightly closed container, protected from light, and kept out of the sight and reach of children.

How should Fertyl be stored and disposed of?

How to Store and Dispose of Fertyl (Clomiphene Citrate)

The medicine must be stored at Controlled Room Temperature, typically defined as 15 C to 30 C. The tablets should be protected from light and stored in a dry, well-closed container with a child-resistant closure.

Official Storage and Disposal Rules

Requirement Type Official Rule
Temperature and Environment Store between 15 C and 30 C; Do not freeze and protect from heat.
Child Safety Keep out of the sight and reach of children and Store Locked Up (P405).
Disposal Dispose of unused product according to local regulations, preferably via a drug take-back program.

Do not discharge the medicine into sewer systems or water courses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fertyl found in:

A-Z Index: